Substance Abuse/Addiction

New research contends that ketamine can reduce problematic alcohol use but does the data support the claims?

Researchers investigate trends in opioid use, prescriptions, misuse, and access reported by adolescents and young adults.

A new study examines longitudinal, intergenerational patterns associated with marijuana use.

Research illustrates privacy concerns with how mental health applications collect and share users’ data.

Industry-funded continuing medical education (CME) influences physicians to prescribe more opioids, focus less on the consequences.

Twice as many teenagers with ADHD experienced severe psychosis when taking Adderall, as compared to Ritalin, according to a new study.

The Youth-Nominated Support Team intervention invites adolescents to select adults in their life to receive training on how to support them.

“Converging lines of evidence now suggest that depression—a common comorbidity in the setting of chronic pain—may in some patients represent an unrecognized yet potentially reversible harm of opioid therapy.”

An international group of researchers, including several with financial ties to manufacturers of antidepressants, explore possible explanations for why long-term users of antidepressants become chronically depressed.

A new study explores feelings of belongingness as a protective factor for childhood trauma and adult mental health outcomes.

Benzodiazepine prescription practices may be in response to an epidemic of distress, rather than being used to treat specific mental health diagnoses.

Long-term opioid prescribing has not only been shown to not be helpful for chronic pain; it in fact worsens pain by repeatedly causing tolerance and withdrawals (the main symptom of which is pain). This is analogous to how psychiatric drug use, though often helpful initially, ultimately can cause people to become chronically “mentally ill.”

Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.

An international study of college students reveals ubiquitous social and emotional challenges faced by young adults.

Two new articles find that rates of ADHD diagnosis and stimulant prescription continue to rise all over the world.

Hallucinations and other psychotic symptoms have been reported after methylphenidate (Ritalin) treatment for ADHD.

New research examines important factors of adherence when prescribing exercise to treat depression.

New data shows that calls to US poison control centers have increased significantly for children taking stimulant ADHD drugs.

A new study examines the extent to which patterns in prescription drug misuse and substance use disorder symptoms can be predicted by education level

Study of students without an ADHD diagnosis finds that stimulants (Adderall) have little impact on cognitive performance.

Experiencing moderate to severe pain, or having at least moderate life interference from pain, doubles risk for anxiety or depression.

Researchers Identify risk factors for long-term benzodiazepine use to prevent harmful effects.

New research demonstrates that children diagnosed with ADHD at younger ages are more likely than those diagnosed later to receive multiple medications within five years of their diagnosis.

Researchers report that dangerous side effects are not being adequately reported in the trials of ketamine for depression.

A large review and meta-analysis of 167 studies across 60 years dissects placebo-controlled randomized controlled trials of antipsychotic drugs.